āagman

Not investment advice. Data and computed figures, for information only.

Cohance Lifesciences Ltd

NSE: COHANCE
₹459.95
+₹14.35 (+3.22%)
NSE · 15 Oct 2026, close
NSE
As of 31 Mar 2026
Market Cap
₹16,873 Cr
CMP
₹459.95
52-wk High / Low
₹918 / 267
P/E
157.0
P/B
4.3
Book Value
₹102.0
Div Yield
0.00%
ROCE
6.0%
ROE
4.9%
Face Value
₹1
D/E
0.10

Price−49.2% over 1Y

āagman read

Computed by āagman
Derived from 8 years and 14 quarters of filings. Not reported by the company.
As of 15 Oct 2026
How we compute these
Piotroski F-Score
4
/ 9
4 of 9 F-score tests passed
Graham Number
₹104
√(22.5 × EPS × book value per share)
ROIC
4.0%
vs 11.2% sector median
Cash flow to profit
2.45
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
−2,016
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
4.9%
ROE × earnings retention ratio
ROE stability
8.9
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom +0.00FII +0.91DII −1.70
Latest quarter vs the previous one
Cash-accrual divergence
−3.9%
of assets
Low = accruals track cash flow
Strengths
+Price trades above its 200-day moving average (1.1x)
Watch-outs
−Latest ROCE of 6% trails the sector median of 17%
−Price is 49.9% below its 52-week high
−Annualised volatility of 49.1% is in the high band (≥45%)
−Promoter holding fell by 2.5pp over the last year

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Consolidated basis (as filed) · ₹ Cr · 13 quarters
As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales348231220253488604676840549556545619422
Expenses181133154180363398439611437435449520421
Operating Profit16798667312520523722911212195991
OPM %48.0%42.4%30.0%28.9%25.6%33.9%35.1%27.3%20.4%21.8%17.4%16.0%0.2%
Other Income11201417191622−46161−1812
Interest102210101110109997
Depreciation13121317313844544544475150
Profit before tax164105657110317420516163844120−43
Net Profit121804753751381531174666298−45
EPS (₹)4.743.131.842.102.965.446.014.731.281.940.960.51−0.63

Profit & Loss

As of 30 Jun 2026
Consolidated · ₹ Cr · 8 years + TTM
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales3788341,0101,3201,3401,0512,6082,2692,142
Expenses2064495677387666451,8111,8411,825
Operating Profit172385443582574406797427316
OPM %45.5%46.2%43.9%44.1%42.8%38.6%30.6%18.8%14.8%
Other Income16668133466253411
Interest323129137413734
Depreciation122432394855167187192
Profit before tax158405468668560406643207101
Net Profit10931736245441130048415059
EPS (₹)—12.4514.2317.8316.1611.8019.144.682.78

Balance Sheet

As of 30 Jun 2026
Consolidated · ₹ Cr
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital013252525252538—
Reserves5788321,1551,5021,7102,0253,6233,873—
Borrowings83186143977065486400—
Other Liabilities1231421512051601381,3461,415—
Total Liabilities7831,1731,4741,8301,9662,2545,4805,727—
Fixed Assets2713574415346636703,1073,369—
CWIP1111029630165179334178—
Investments7338542598536904337529—
Other Assets3943763956676015011,7021,652—
Total Assets7831,1731,4741,8301,9662,2545,4805,727—

Cash Flows

As of 31 Mar 2026
Consolidated · ₹ Cr
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity50407383330457358673368
Cash from Investing Activity−65−413−311−136−195−362−388−251
Cash from Financing Activity267−76−156−242−14−327−165
Net Cash Flow111−53720−18−42−48

Ratios

As of 31 Mar 2026
8 periods
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %—50.040.041.032.019.021.06.0
ROE %———————4.9
EPS (₹)—12.4514.2317.8316.1611.8019.144.68
Book Value (₹)———————102.0
Face Value (₹)———————1
P/E———————157.0
Div Yield %———————0.00
NPM %28.835.233.631.229.727.018.26.6
OPM %45.046.044.044.043.039.031.019.0
D/E0.140.220.120.060.040.030.130.10
P/B———————4.3

Growth

As of 11 Oct 2026
Compounded sales growth
5 years+18.0%
3 years+19.0%
TTM−20.0%
Compounded profit growth
5 years−12.0%
3 years−23.0%
TTM−77.0%
Stock price CAGR
5 years−4.0%
3 years−9.0%
Last year−51.0%
Return on equity
5 years15.0%
3 years11.0%
Last year5.0%

Shareholding pattern

As of 30 Jun 2025
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
Promoters60.00%60.00%60.00%60.00%60.00%50.10%50.10%57.49%57.49%
FIIs0.00%0.00%6.93%8.56%9.47%9.54%11.05%5.59%6.50%
DIIs8.19%8.19%5.52%6.56%11.43%17.24%16.60%21.79%20.09%
Government0.00%0.00%0.00%0.00%0.00%0.01%0.01%0.01%0.01%
Public31.81%31.81%27.55%24.88%19.10%23.11%22.24%15.11%15.92%
No. of shareholders60,68460,68475,20785,72572,88568,93286,32585,23099,149
Change since Jun 2023 (pp)
Promoters −2.51FIIs +6.50DIIs +11.90Public −15.89

Documents

As of 11 Oct 2026
Announcements
Grant Of Stock Options To Certain Eligible Employees Of The CompanyAnnouncement under Regulation 30 (LODR)-Change in ManagementCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018ESG Rating By Crisil ESG Ratings & Analytics LimitedClosure of Trading Window
Annual reports
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022
Credit ratings
Rating updateRating updateRating updateRating updateRating update
Concalls
Aug 2026TranscriptAug 2026PPTAug 2026RecordingMay 2026TranscriptMay 2026PPTMay 2026RecordingFeb 2026TranscriptFeb 2026PPTFeb 2026RecordingNov 2025TranscriptNov 2025PPTNov 2025Transcript

Corporate actions

As of 9 Sep 2022
9 Sep 2022DIVIDENDInterim Dividend - Re 1 Per Share/Special Dividend- Rs 5 Per Share—
13 May 2022DIVIDENDInterim Dividend - Re 1 Per Share/Special Dividend - Re 1 Per Share—
15 Feb 2022DIVIDENDInterim Dividend - Re 1 Per Share/ Special Dividend - Rs 2 Per Share—
13 Aug 2021DIVIDEND Annual General Meeting/Dividend - Re 1 Per Share—
17 Feb 2021DIVIDEND Interim Dividend - Re 1 Per Share—
25 Sep 2020BONUS Bonus 1:1—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman